Global Enoxaparin Sodium Market Growth 2025-2031

Global Enoxaparin Sodium Market Growth 2025-2031

The global Enoxaparin Sodium market size is predicted to grow from US$ 3504 million in 2025 to US$ 5377 million in 2031; it is expected to grow at a CAGR of 7.4% from 2025 to 2031.

Enoxaparin sodium is an anticoagulant medication (blood thinner). It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. It is also used during hemodialysis.

The core global manufacturers of enoxaparin sodium include Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi, Rovi and Amphastar. The top three manufacturers account for approximately 66% of the global share. Sanofi is the world's largest manufacturer of enoxaparin sodium, with a market share of approximately 42%.

Europe is the world's largest enoxaparin sodium market, accounting for nearly 60% of the market share. The second and third places are North America and Asia, accounting for 19% and 16% respectively.

In terms of product type, 60 mg/0.6mL occupies a dominant position, accounting for 29% of the market share. At the same time, in terms of sales channels, hospitals and clinics are the main sales channels, accounting for 80%.

LP Information, Inc. (LPI) ' newest research report, the “Enoxaparin Sodium Industry Forecast” looks at past sales and reviews total world Enoxaparin Sodium sales in 2024, providing a comprehensive analysis by region and market sector of projected Enoxaparin Sodium sales for 2025 through 2031. With Enoxaparin Sodium sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enoxaparin Sodium industry.

This Insight Report provides a comprehensive analysis of the global Enoxaparin Sodium landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enoxaparin Sodium portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Enoxaparin Sodium market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enoxaparin Sodium and breaks down the forecast by Type, by Sales Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enoxaparin Sodium.

This report presents a comprehensive overview, market shares, and growth opportunities of Enoxaparin Sodium market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
20 mg/0.2mL
30 mg/0.3mL
40 mg/0.4mL
60 mg/0.6mL
80 mg/0.8mL
100 mg/1mL
120 mg/0.8mL
150 mg/1mL
300mg/3mL

Segmentation by Sales Channel:
Hospital & Clinic
Pharmacy
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sanofi
Techdow (Hepalink)
Teva
Nanjing King-friend
Rovi
Fresenius Kabi
Fosun Pharma(Gland Pharma)
Amphastar
Sandoz (Novartis)
Apotex
Huadong Medicine
Cipla
Taj Pharma
Chengdu Baiyu Pharmaceutical
Changzhou Qianhong Bio-pharma
Beijing SL Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Enoxaparin Sodium market?

What factors are driving Enoxaparin Sodium market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Enoxaparin Sodium market opportunities vary by end market size?

How does Enoxaparin Sodium break out by Type, by Sales Channel?

Please note: The report will take approximately 2 business days to prepare and deliver.